慢性淋巴细胞白血病(CLL)患者诊断时合并症与生存及最终死因的关系:一项前瞻性队列研究
该前瞻性队列研究纳入2002年6月至2014年11月间诊断的1143例CLL患者,评估诊断时合并症与生存及死因的关系。中位随访6年后225例死亡,其中CLL进展占46%、感染占8%、其他癌症占19%、合并症占27%。多因素分析显示较高的CCI评分和较多主要合并症与较短的非CLL特异性生存相关,但与CLL特异性生存无关。
要点
- 诊断时93%的CLL患者至少有一种合并症,中位数为3种。
- 中位随访6年,225例死亡,CLL进展为最常见死因(46%)。
- 较高CCI评分和较多主要合并症与较短的非CLL特异性生存相关。
核心结论
- CLL及其相关并发症(感染和第二癌症)是CLL患者的主要死因,与诊断时CCI评分和合并症数量无关。
研究设计与样本
- 前瞻性队列研究,纳入2002年6月至2014年11月间诊断的1143例CLL患者,系统随访并评估诊断时合并症与生存及死因的关系。
主要发现
- 1061例(93%)患者在CLL诊断时至少有一种合并症,中位数为3种。
- 89%的患者诊断时Charlson合并症指数(CCI)评分为低-中等。
- 中位随访6年,225例患者死亡;死因为CLL进展85例(46%)、感染14例(8%)、其他癌症35例(19%)、合并症50例(27%)。
- 多因素分析显示较高的CCI评分和较多主要合并症与较短的非CLL特异性生存相关,但与CLL特异性生存无关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ultimate cause of death for most patients with newly diagnosed chronic lymphocytic leukaemia (CLL) and its relationship to co-morbid health conditions is poorly defined. We conducted a prospective cohort study that systematically followed 1143 patients diagnosed with CLL between June 2002 and November 2014. Comorbid health conditions at the time of CLL diagnosis and their relationship to survival and cause of death were evaluated. Collectively, 1061 (93%) patients had at least one co-morbid health condition at the time of CLL diagnosis (median number 3). Despite this, 89% of patients had a low-intermediate Charlson Comorbidity Index score (CCI) at diagnosis. After a median follow-up of 6 years, 225 patients have died. Death was due to CLL progression in 85 (46%) patients, infection in 14 (8%) patients, other cancer in 35 (19%) patients and comorbid health conditions in 50 (27%) patients. Higher CCI score and a greater number of major comorbid health conditions at the time of CLL diagnosis was associated with shorter non-CLL specific survival, but not with shorter CLL-specific survival on multivariate analysis. In conclusion, CLL and CLL-related complications (infections and second cancers) are the overwhelming cause of death in patients with CLL, regardless of CCI score and number of comorbid health conditions at diagnosis.
引用
- Strati P, Parikh SA, Chaffee KG, et al. Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study. Br J Haematol. 2017. PMID: 28580636. doi:10.1111/bjh.14785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。